Moderna Stock: Buy, Sell, or Hold?
While the COVID-19 pandemic has caused upheaval throughout the world, it has also served as a major catalyst for some stocks. You can definitely include Moderna (NASDAQ: MRNA) in the group. The biotech's shares have more than tripled year to date and at one point more than quadrupled.
This kind of meteoric rise tends to prompt some investors to wonder if they should buy Moderna. Others who invested in the biotech stock early on might be asking themselves if it's time to sell or if they should hold onto their shares.
Should you buy, sell, or hold Moderna stock? Here are the arguments for each move -- and what appears to be the best approach overall.
Source Fool.com


